AR028968A1 - Derivados heterociclicos de la aminoalquilpiridina como psicofarmacos - Google Patents
Derivados heterociclicos de la aminoalquilpiridina como psicofarmacosInfo
- Publication number
- AR028968A1 AR028968A1 ARP010102933A ARP010102933A AR028968A1 AR 028968 A1 AR028968 A1 AR 028968A1 AR P010102933 A ARP010102933 A AR P010102933A AR P010102933 A ARP010102933 A AR P010102933A AR 028968 A1 AR028968 A1 AR 028968A1
- Authority
- AR
- Argentina
- Prior art keywords
- hal
- groups
- optionally
- ring structures
- mono
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Derivados heterocíclicos de la aminoalquilpiridina de la formula (1) donde R1 es el radical de un heterociclo con 1 a 3 estructuras de anillo, donde cada estructura de anillo es saturada, no saturada o aromática, y opcionalmente está fusionada con otras estructuras de anillo para dar un sistema de anillos condensado, presentando el heterociclo un total de 1 a 4 átomos de N, O y/o S en las estructuras de anillo y opcionalmente está mono-, bi- o trisustituido por uno o varios de los grupos ûA, -OR4, -N(R4)2, -NO2, -CN, Hal, -COOR4, -CON(R4)2, -COR4, =O; R2 es un grupo fenilo, opcionalmente mono -, bi- tri ûtetra o pentasustituido por uno o varios de los grupos Hal, A, -O-A, -NO2 o ûCN, o bien un grupo tienilo, opcionalmente mono o bisustituido con uno o varios de los grupos Hal, A, -O-A, -NO2, -CN o tienilo; -X- es ûO-, -S-, sulfinilo, sulfonilo, -C(R4)2; -Y- es [C(R4)2]n-; -Z- es ûC(R4)2; n es 1, 2, 3 o 4; así como sus sales y solvatos compatibles y su uso como medicamento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10029371A DE10029371A1 (de) | 2000-06-20 | 2000-06-20 | Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka |
Publications (1)
Publication Number | Publication Date |
---|---|
AR028968A1 true AR028968A1 (es) | 2003-05-28 |
Family
ID=7645750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010102933A AR028968A1 (es) | 2000-06-20 | 2001-06-20 | Derivados heterociclicos de la aminoalquilpiridina como psicofarmacos |
Country Status (21)
Country | Link |
---|---|
US (1) | US6960599B2 (es) |
EP (1) | EP1292592B1 (es) |
JP (1) | JP5160715B2 (es) |
KR (1) | KR20030011092A (es) |
CN (1) | CN1437595A (es) |
AR (1) | AR028968A1 (es) |
AT (1) | ATE506357T1 (es) |
AU (2) | AU7845701A (es) |
BR (1) | BR0111816A (es) |
CA (1) | CA2410594C (es) |
CZ (1) | CZ20023955A3 (es) |
DE (2) | DE10029371A1 (es) |
ES (1) | ES2363668T3 (es) |
HU (1) | HUP0301316A2 (es) |
MX (1) | MXPA02012262A (es) |
NO (1) | NO20026104L (es) |
PL (1) | PL358672A1 (es) |
RU (1) | RU2003100514A (es) |
SK (1) | SK17122002A3 (es) |
WO (1) | WO2001098293A1 (es) |
ZA (1) | ZA200209727B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6800652B2 (en) | 2002-08-16 | 2004-10-05 | Pfizer Inc. | Diaryl compounds |
GB0219154D0 (en) * | 2002-08-16 | 2002-09-25 | Pfizer Ltd | Diaryl compounds |
DE10254596A1 (de) * | 2002-11-22 | 2004-06-03 | Merck Patent Gmbh | Indolderivate |
SI1569907T1 (sl) * | 2002-12-13 | 2016-06-30 | Ym Biosciences Australia Pty Ltd | Na nikotinamidu osnovani kinazni inhibitorji |
KR100679480B1 (ko) * | 2004-05-18 | 2007-02-07 | 엄기형 | 지하층 바닥에 시공되는 배수판 |
US8152380B2 (en) * | 2006-07-07 | 2012-04-10 | Federal-Mogul World Wide, Inc. | Sleeve bearing assembly and method of construction |
KR101043454B1 (ko) * | 2009-07-10 | 2011-06-23 | 현대산업개발 주식회사 | 건축 지하구조물의 마감 조립체 |
US9012651B2 (en) * | 2011-03-24 | 2015-04-21 | Abbvie Inc. | TRPV3 modulators |
TW202246215A (zh) | 2015-12-18 | 2022-12-01 | 美商亞德利克斯公司 | 作為非全身tgr5促效劑之經取代之4-苯基吡啶化合物 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5002935A (en) * | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
US5177088A (en) | 1991-04-17 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted 3-(pyridinylamino)-indoles |
TW203047B (es) * | 1991-06-21 | 1993-04-01 | American Home Prod | |
JPH05125024A (ja) * | 1991-11-05 | 1993-05-21 | Yamanouchi Pharmaceut Co Ltd | 新規なアリールオキシアルキルアミン誘導体又はその塩 |
JPH05255302A (ja) * | 1992-03-09 | 1993-10-05 | Yamanouchi Pharmaceut Co Ltd | 新規なクロマニルオキシアルキルアミン誘導体 |
DE4226527A1 (de) * | 1992-08-11 | 1994-02-17 | Merck Patent Gmbh | 1,4-Benzodioxanderivate |
JPH07309867A (ja) * | 1994-05-19 | 1995-11-28 | Asahi Chem Ind Co Ltd | トリプタミン誘導体およびその用途 |
PT707007E (pt) | 1994-10-14 | 2002-06-28 | Merck Patent Gmbh | Derivados amino(tio)eter como agentes activos no snc |
JPH0940648A (ja) * | 1995-08-02 | 1997-02-10 | Yamanouchi Pharmaceut Co Ltd | 新規な8−(2−アミノアルコキシ)キノリン誘導体 |
PT923548E (pt) * | 1996-08-27 | 2003-06-30 | Wyeth Corp | 4-aminoetoxi-indolos como agonistas d2 da dopaminae como ligandos da 5ht1a |
-
2000
- 2000-06-20 DE DE10029371A patent/DE10029371A1/de not_active Withdrawn
-
2001
- 2001-06-19 EP EP01956484A patent/EP1292592B1/de not_active Expired - Lifetime
- 2001-06-19 US US10/311,286 patent/US6960599B2/en not_active Expired - Fee Related
- 2001-06-19 SK SK1712-2002A patent/SK17122002A3/sk unknown
- 2001-06-19 DE DE50115858T patent/DE50115858D1/de not_active Expired - Lifetime
- 2001-06-19 CA CA2410594A patent/CA2410594C/en not_active Expired - Fee Related
- 2001-06-19 CZ CZ20023955A patent/CZ20023955A3/cs unknown
- 2001-06-19 PL PL01358672A patent/PL358672A1/xx unknown
- 2001-06-19 KR KR1020027017265A patent/KR20030011092A/ko not_active Application Discontinuation
- 2001-06-19 CN CN01811541A patent/CN1437595A/zh active Pending
- 2001-06-19 BR BR0111816-1A patent/BR0111816A/pt not_active IP Right Cessation
- 2001-06-19 JP JP2002504249A patent/JP5160715B2/ja not_active Expired - Fee Related
- 2001-06-19 RU RU2003100514/04A patent/RU2003100514A/ru not_active Application Discontinuation
- 2001-06-19 MX MXPA02012262A patent/MXPA02012262A/es unknown
- 2001-06-19 AT AT01956484T patent/ATE506357T1/de active
- 2001-06-19 HU HU0301316A patent/HUP0301316A2/hu unknown
- 2001-06-19 ES ES01956484T patent/ES2363668T3/es not_active Expired - Lifetime
- 2001-06-19 AU AU7845701A patent/AU7845701A/xx active Pending
- 2001-06-19 WO PCT/EP2001/006915 patent/WO2001098293A1/de active Application Filing
- 2001-06-19 AU AU2001278457A patent/AU2001278457B2/en not_active Ceased
- 2001-06-20 AR ARP010102933A patent/AR028968A1/es unknown
-
2002
- 2002-11-29 ZA ZA200209727A patent/ZA200209727B/en unknown
- 2002-12-19 NO NO20026104A patent/NO20026104L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE10029371A1 (de) | 2002-01-03 |
EP1292592B1 (de) | 2011-04-20 |
PL358672A1 (en) | 2004-08-09 |
CA2410594A1 (en) | 2001-12-27 |
ZA200209727B (en) | 2004-03-30 |
SK17122002A3 (sk) | 2003-04-01 |
HUP0301316A2 (hu) | 2003-08-28 |
US6960599B2 (en) | 2005-11-01 |
NO20026104D0 (no) | 2002-12-19 |
KR20030011092A (ko) | 2003-02-06 |
NO20026104L (no) | 2002-12-19 |
CN1437595A (zh) | 2003-08-20 |
BR0111816A (pt) | 2003-06-24 |
ES2363668T3 (es) | 2011-08-11 |
ATE506357T1 (de) | 2011-05-15 |
AU2001278457B2 (en) | 2006-10-19 |
AU2001278457C1 (en) | 2002-01-02 |
AU7845701A (en) | 2002-01-02 |
CA2410594C (en) | 2010-10-26 |
RU2003100514A (ru) | 2004-07-20 |
EP1292592A1 (de) | 2003-03-19 |
CZ20023955A3 (cs) | 2003-05-14 |
US20040019044A1 (en) | 2004-01-29 |
JP5160715B2 (ja) | 2013-03-13 |
WO2001098293A1 (de) | 2001-12-27 |
DE50115858D1 (de) | 2011-06-01 |
JP2004501148A (ja) | 2004-01-15 |
MXPA02012262A (es) | 2003-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2721268T3 (es) | Compuestos de pirazolo[1,5-a]pirimidina-5,7-diamina como inhibidores de CDK y su uso terapéutico | |
AR011101A1 (es) | Compuesto derivado de acidos arilsulfonilaminohidroxiamicos y composicion farmaceutica que lo contiene | |
AR051735A1 (es) | Inhibidores pirrolicos de la proteina quinasa erk, sintesis e intermediarios de los mismos. | |
AR015007A1 (es) | Compuestos de 12,13-ciclopropano epotilona y sales, solvatos e hidratos de los mismos | |
AR091400A2 (es) | Composicion farmaceutica que comprende derivados de sulfamida, proceso para prepararla y uso de dichos compuestos para preparar medicamentos | |
ECSP055747A (es) | Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos | |
BR0114657A (pt) | Compostos de benzamida e seu uso | |
PE20212302A1 (es) | Inhibidores de apol1 y sus metodos de uso | |
AR049646A1 (es) | Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados | |
AR063022A1 (es) | Derivados de indol antagonistas del receptor de glucagon, composiciones farmaceuticas que los contienen y usos para tratar diabetes mellitus tipo 2 y estados patologicos relacionados. | |
CO5221069A1 (es) | Concentrado de suspensiones, no acuosos o pobres en agua, de mezclas de sustancias activas para la proteccion de plantas | |
AR058776A1 (es) | Compuesto de piridina condensado | |
CR9459A (es) | Derivados benzodioxano y benzodioxolano y usos de los mismos | |
ECSP034865A (es) | Resolución óptica de (1-benzilo-4-metilopiperidina-3-il)-metilamina y su uso para la preparación de derivados de pirrolo 2,3-pirimidina como inhibidores de proteina quinasas | |
ES2192081T3 (es) | Derivados de purina antivirales. | |
AR033678A1 (es) | Derivados de quinolina, procedimiento para prepararlos, uso de los mismos para la preparacion de medicamentos y los medicamentos que contienen dichos derivados | |
AR019365A1 (es) | Compuesto de 1-piperidin-3-fenil-butil-naftamida, proceso para prepararlo, composicion farmaceutica y uso para fabricar un medicamento util para eltratamiento de una enfermedad por antagonistas de taquicininas neuropeptidicas endogenas | |
UY28848A1 (es) | Antagonistas de cgrp seleccionados, procedimientos para su preparación, y su empleo como medicamentos | |
ES2158778B1 (es) | Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen. | |
AR028968A1 (es) | Derivados heterociclicos de la aminoalquilpiridina como psicofarmacos | |
DK0639179T3 (da) | 23-oxaderivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemidler | |
AR042439A1 (es) | Concentrado para suspender en aceites | |
AR045999A1 (es) | Compuesto de eter de piperidina, su uso para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para prepararlo | |
AR035570A1 (es) | Derivados de isotiazol | |
ES2115220T3 (es) | Nuevo uso de compuestos bis-heterociclicos como agentes antiinflamatorios y composiciones farmaceuticas de los mismos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |